Stockscreener 앱 받기
7.2222
1.44%
+0.1022
전일 마감가:
$7.12
열려 있는:
$7.04
하루 거래량:
10,179
시가총액:
$454.26M
수익:
-
순이익/손실:
$-36.95M
주가수익비율:
-7.8502
EPS:
-0.92
순현금흐름:
$-33.46M
1주 성능:
-12.35%
1개월 성능:
+3.77%
6개월 성능:
+202.18%
1년 성능:
+42.73%
1일 변동 폭
$7.04
$7.24
52주 변동 폭
$2.18
$13.68
Larimar Therapeutics Inc Stock (LRMR) Company Profile
명칭
Larimar Therapeutics Inc
전화
844 511 9056
주소
Three Bala Plaza East, Suite 506, Bala Cynwyd, PA
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-10-19 | 개시 | Guggenheim | Buy |
| 2022-02-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-02-10 | 개시 | JMP Securities | Mkt Outperform |
| 2021-02-01 | 개시 | William Blair | Outperform |
Larimar Therapeutics Inc 주식(LRMR)의 최신 뉴스
Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development
GlobeNewswire Inc.
Larimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich’s Ataxia
GlobeNewswire Inc.
Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference
GlobeNewswire Inc.
Over $37M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Benzinga
Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
GlobeNewswire Inc.
Cisco Issues Weak Outlook, Joins Fastly, Herbalife And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Benzinga
Larimar Therapeutics Inc (LRMR) 재무 분석
Larimar Therapeutics Inc (LRMR) 순이익 2024
LRMR은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -36.95M 달러로 보고했으며, 전년대비 -4.51% 감소했습니다.
Larimar Therapeutics Inc (LRMR) 현금흐름 2024
2023-12-31 종료 분기에 LRMR은 현금흐름(지난 12개월)으로 -33.46M 달러를 기록했으며, 전년 대비 -20.93% 감소했습니다.
Larimar Therapeutics Inc (LRMR) 주당 순이익 2024
LRMR이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -0.84달러이며, 전년 대비 +45.45% 성장했습니다.
Larimar Therapeutics Inc 주식 (LRMR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| THOMAS FRANK E | Director |
Feb 14 '24 |
Buy |
11.00 |
2,000 |
22,000 |
2,000 |
| Shankar Gopi | Chief Development Officer |
Dec 07 '23 |
Buy |
3.73 |
5,000 |
18,662 |
5,000 |
| Celano Michael | Chief Financial Officer |
May 17 '23 |
Buy |
3.73 |
5,000 |
18,632 |
112,746 |
| BEN-MAIMON CAROLE | President and CEO |
May 17 '23 |
Buy |
3.71 |
5,000 |
18,525 |
266,829 |
| Truitt Joseph | Director |
May 17 '23 |
Buy |
3.73 |
2,750 |
10,258 |
2,750 |
0.64%
0.31%
자본화:
|
볼륨(24시간):